Published in Hepatology on August 01, 2000
Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88
The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol (2002) 1.11
Heterogeneity of the intrahepatic biliary epithelium. World J Gastroenterol (2006) 1.07
Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev (2010) 0.93
Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature. Dig Dis Sci (2007) 0.81
Liver disease in cystic fibrosis: an update. Hepat Mon (2013) 0.77
Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease? Can Respir J (2016) 0.77
Unexpected diagnosis of cystic fibrosis at liver biopsy: a report of four pediatric cases. Virchows Arch (2007) 0.77
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet (1992) 4.23
Atopy in children of families with an anthroposophic lifestyle. Lancet (1999) 3.41
Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology (2001) 2.85
A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol (1991) 2.46
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Early BCG vaccination and development of atopy. Lancet (1997) 2.23
Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax (2007) 2.07
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J (2003) 1.97
CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med (1993) 1.91
Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax (2004) 1.86
Rectal cancer risk in patients treated for familial adenomatous polyposis. The Leeds Castle Polyposis Group. Br J Surg (1992) 1.81
Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun (1989) 1.77
In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin Exp Immunol (1982) 1.71
Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope (1997) 1.67
Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ (2009) 1.67
HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology (1995) 1.66
Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax (1990) 1.65
Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol (1986) 1.63
Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J (2003) 1.62
Targeting of human dendritic cells by autologous NK cells. J Immunol (1999) 1.62
Increased bronchial chloride concentration in cystic fibrosis. Scand J Clin Lab Invest (1989) 1.60
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther (2014) 1.60
Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol (1999) 1.58
Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology (1996) 1.58
Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol (2002) 1.58
Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab (2000) 1.56
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J (2000) 1.54
Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr Scand (1984) 1.54
Bile acid kinetics and biliary lipid composition in cystic fibrosis. J Hepatol (1996) 1.51
Hepatitis delta virus infection in French male HBsAg-positive homosexuals. Hepatology (1989) 1.51
Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J Clin Microbiol (1987) 1.49
Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol (2001) 1.49
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Aliment Pharmacol Ther (2012) 1.49
Allergic diseases and atopic sensitization in children related to farming and anthroposophic lifestyle--the PARSIFAL study. Allergy (2006) 1.49
Effectiveness of occlusive bedding in the treatment of atopic dermatitis--a placebo-controlled trial of 12 months' duration. Allergy (2001) 1.46
Prevalence of a haemochromatosis among men with clinically significant bradyarrhythmias. Eur Heart J (1989) 1.45
European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol (2001) 1.44
Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum (1988) 1.44
Pityrosporum orbiculare and atopic eczema. Allergy (1993) 1.42
Detection and characterization of focal liver lesions with contrast-enhanced ultrasonography in patients with hepatitis C-induced liver cirrhosis. Acta Radiol (2008) 1.42
Similar T helper Th2-like cytokine mRNA expression in vernal keratoconjunctivitis regardless of atopic constitution. Allergy (2002) 1.40
Natural history of liver disease in cystic fibrosis. Hepatology (1999) 1.40
Lack of antagonism to Ni2+ and Co2+ contact allergy from other essential divalent metal ions. Contact Dermatitis (1998) 1.38
Liver damage from flucloxacillin, cloxacillin and dicloxacillin. J Hepatol (1992) 1.38
Large tunable Rashba spin splitting of a two-dimensional electron gas in Bi2Se3. Phys Rev Lett (2011) 1.37
Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection. J Virol (1991) 1.35
PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab Invest (2000) 1.32
Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax (2005) 1.31
Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. Clin Exp Immunol (1984) 1.29
Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. Proc Natl Acad Sci U S A (1986) 1.28
Alpha 4 integrin directs virus-activated CD8+ T cells to sites of infection. J Immunol (1995) 1.28
Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury. Lab Invest (2001) 1.27
Excretion of 3beta-hydroxy-5-cholenoic and 3a-hydroxy-5a-cholanoic acids in urine of infants with biliary atresia. FEBS Lett (1971) 1.26
3-Oxo-delta 4 bile acids in liver disease. Lancet (1988) 1.24
Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology (1998) 1.21
An increased number of gamma/delta T-cells and gastric epithelial cell expression of the groEL stress-protein homologue in Helicobacter pylori-associated chronic gastritis of the antrum. Am J Gastroenterol (1991) 1.20
Lymphocytic choriomeningitis virus infection is associated with long-standing perturbation of LFA-1 expression on CD8+ T cells. Scand J Immunol (1995) 1.19
Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population. Infection (1995) 1.19
Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand J Immunol (2004) 1.19
Exosomes - nanovesicles with possible roles in allergic inflammation. Allergy (2008) 1.19
Bile acids and pancreatic enzymes during absorption in the newborn. Acta Paediatr Scand (1972) 1.17
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular? Am J Clin Pathol (1997) 1.15
Human keratinocytes express HLA-DR antigens in the tuberculin reaction. Scand J Immunol (1984) 1.15
Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis. Acta Paediatr Scand (1986) 1.15
Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut (1994) 1.15
Detection of Mala f and Mala s allergen sequences within the genus Malassezia. Med Mycol (2003) 1.13
Bacterial and fungal agents in house dust and wheeze in children: the PARSIFAL study. Clin Exp Allergy (2005) 1.13
Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol (1997) 1.12
Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol (1997) 1.11
Inoculation of barrier-born pigs with Helicobacter pylori: a useful animal model for gastritis type B. Infect Immun (1990) 1.11
Selective cloning of allergens from the skin colonizing yeast Malassezia furfur by phage surface display technology. J Invest Dermatol (1999) 1.11
Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum (1990) 1.11
Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol (1991) 1.11
Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur Respir J (2001) 1.11
A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol (2000) 1.10
Class II transplantation antigens: distribution in tissues and involvement in disease. Scand J Immunol (1985) 1.08
Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy (2012) 1.08
Morphological findings in the liver of children with cystic fibrosis: a light and electron microscopical study. Hepatology (1986) 1.08
AIDS-related cholangitis: diagnostic features and course in 15 patients. J Hepatol (1993) 1.08
Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol (1993) 1.07
Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests. Gut (1990) 1.06
Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol (1995) 1.05
Virtual reality colonoscopy simulation: a compulsory practice for the future colonoscopist? Endoscopy (2005) 1.05
HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med (1998) 1.05
Increased frequency of sister chromatid exchanges in cigarette smokers. Hereditas (1978) 1.04
Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. Eur J Clin Nutr (2010) 1.04
Lifestyle factors and sensitization in children - the ALADDIN birth cohort. Allergy (2011) 1.02
Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis. Thorax (1986) 1.02
Duodenal adenomatosis in familial adenomatous polyposis. DAF Project Group. Int J Colorectal Dis (1995) 1.02
The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1. Eur J Biochem (1997) 1.01
Ultrastructural liver pathology in patients with minimal liver disease and alpha 1-antitrypsin deficiency: a comparison between heterozygous and homozygous patients. Hepatology (1984) 1.01
Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis. J Antimicrob Chemother (1983) 1.01
Multiple epitopes on cartilage type II collagen are accessible for antibody binding in vivo. Autoimmunity (1991) 1.01